Selected Publications

Morris-Blanco KC, Chokkalla AK, Arruri V, Jeong S, Probelsky SM, Vemuganti R (2022). Epigenetic mechanisms and potential therapeutic targets in stroke. J Cereb Blood Flow Metab. Doi: 10.1177/0271678X221116192. Online ahead of print.

Chokkalla AK, Jeong S, Mehta SL, Davis CK, Morris-Blanco KC, Bathula S, Qureshi SS, Vemuganti R (2022). Cerebroprotective Role of N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) After Experimental Stroke. Stroke.  doi: 10.1161/STROKEAHA.122.040401. Online ahead of print.

Morris-Blanco KC, Chokkalla AK, Kim T, Bathula S, Bertogliat MJ, Gaillard AB, Vemuganti R (2022). High-dose Vitamin C prevents secondary brain damage after stroke via epigenetic reprogramming of neuroprotective genes. Translational Stroke Research. 13(6):1017-1036.

Mehta SL, Chokkalla AK, Kim T, Bathula S, Chelluboina B, Morris-Blanco KC, Holmes A, Banerjee A, Chauhan A, Lee J, Venna VR, McCullough LD, Vemuganti R (2021). Long Noncoding RNA Fos Downstream Transcript Is Developmentally Dispensable but Vital for Shaping the Poststroke Functional Outcome. Stroke. 52(7):2381-2392.

Morris-Blanco KC, Chokalla AK, Bertogliat MJ, Vemuganti R (2021).  TET3 Regulates DNA Hydroxymethylation of Neuroprotective Genes Following Focal Ischemia. J Cereb Blood Flow Metab. 41(3):590-603.

Morris-Blanco KC, Kim T, Lopez MS, Bertogliat MJ, Chelluboina C, Vemuganti R (2019). Induction of DNA hydroxymethylation protects the brain after stroke. Stroke. 50(9):2513-2521.

Kim T, Mehta S, Morris-Blanco KC, Chokkalla AK, Chelluboina B, Lopez M, Sullivan R, Kim HT, Cook T, Kim JY, Kim H, Kim C, Vemuganti R. (2018). The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein. Science Signaling.11(560).

Li GMorris-Blanco KC**, Lopez MS, Yang T, Zhao H, Vemuganti R, Luo Y. (2017). Impact of microRNAs on ischemic stroke: From pre- to post-disease. Progress in Neurobiology. 163-164:59-78. **co-first author

Full Bibliography at